Axogen (AXGN) Net Margin (2010 - 2026)
Axogen's quarterly Net Margin came in at 4.49% in Q1 2026, up 301.0% year-on-year from 1.12% in Q1 2025, and up 75.86% quarter-over-quarter from 18.59% in Q4 2025.
Axogen has reported Net Margin for 17 years, with the latest figure at 4.49% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 301.0% year-over-year to 4.49%; the trailing twelve-month figure through Mar 2026 stood at 5.67% (down 187.0% YoY), and the FY2025 full-year result was 6.39%, down 86.0% from the prior year.
- Net Margin for Q1 2026 stood at 4.49%, up from 18.59% in the prior quarter.
- The five-year high for Net Margin was 1.1% in Q4 2024, with the low at 37.8% in Q1 2022.
- Average Net Margin over 5 years is 11.79%, with a median of 10.95% recorded in 2023.
- Year-over-year, Net Margin soared 1923 bps in 2023 and plunged 1969 bps in 2025.
- Tracing AXGN's Net Margin over 5 years: stood at 14.3% in 2022, then rose by 23 bps to 10.95% in 2023, then surged by 110 bps to 1.1% in 2024, then sank by 1798 bps to 18.59% in 2025, then soared by 76 bps to 4.49% in 2026.
- The last three Net Margin figures came in at 4.49% (Q1 2026), 18.59% (Q4 2025), and 0.79% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn | -4.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.49% |
| Dec 31, 2025 | -18.59% |
| Sep 30, 2025 | 0.79% |
| Jun 30, 2025 | -0.14% |
| Mar 31, 2025 | -7.49% |
| Dec 31, 2024 | 1.10% |
| Sep 30, 2024 | -3.93% |
| Jun 30, 2024 | -4.98% |
| Mar 31, 2024 | -15.93% |
| Dec 31, 2023 | -10.95% |
| Sep 30, 2023 | -10.87% |
| Jun 30, 2023 | -17.86% |
| Mar 31, 2023 | -18.57% |
| Dec 31, 2022 | -14.30% |
| Sep 30, 2022 | -12.80% |
| Jun 30, 2022 | -23.63% |
| Mar 31, 2022 | -37.80% |
| Dec 31, 2021 | -16.71% |
| Sep 30, 2021 | -22.72% |
| Jun 30, 2021 | -22.90% |
| Mar 31, 2021 | -21.36% |
| Dec 31, 2020 | -18.28% |
| Sep 30, 2020 | -4.23% |
| Jun 30, 2020 | -36.39% |
| Mar 31, 2020 | -33.92% |
| Dec 31, 2019 | -24.86% |
| Sep 30, 2019 | -19.48% |
| Jun 30, 2019 | -26.32% |
| Mar 31, 2019 | -40.80% |
| Dec 31, 2018 | -22.61% |
| Sep 30, 2018 | -18.10% |
| Jun 30, 2018 | -25.29% |
| Mar 31, 2018 | -28.92% |
| Dec 31, 2017 | -23.56% |
| Sep 30, 2017 | -9.35% |
| Jun 30, 2017 | -9.62% |
| Mar 31, 2017 | -26.22% |
| Dec 31, 2016 | -42.51% |
| Sep 30, 2016 | -20.27% |
| Jun 30, 2016 | -26.68% |
| Mar 31, 2016 | -44.70% |
| Dec 31, 2015 | -45.84% |
| Sep 30, 2015 | -36.30% |
| Jun 30, 2015 | -49.51% |
| Mar 31, 2015 | -71.46% |
| Dec 31, 2014 | -115.93% |
| Sep 30, 2014 | -68.15% |
| Jun 30, 2014 | -88.78% |
| Mar 31, 2014 | -135.09% |
| Dec 31, 2013 | -137.66% |
| Sep 30, 2013 | -120.13% |
| Jun 30, 2013 | -120.81% |
| Mar 31, 2013 | -160.41% |
| Dec 31, 2012 | -197.67% |
| Sep 30, 2012 | -112.92% |
| Jun 30, 2012 | -51.17% |
| Mar 31, 2012 | -127.57% |
| Dec 31, 2011 | -156.94% |
| Sep 30, 2011 | -301.81% |
| Jun 30, 2011 | -163.24% |
| Mar 31, 2011 | -237.80% |
| Dec 31, 2010 | -383.70% |
| Sep 30, 2010 | -156.39% |
| Jun 30, 2010 | -7,080.15% |